口腔微生物组放射敏感性预测头颈癌放射性黏膜炎的前瞻性试验
该前瞻性试验纳入63例接受放化疗的头颈癌患者,其中58份样本可用,检测口腔角质细胞离体放射敏感性。34例(58.6%)在中位剂量32 Gy后发生3级口腔黏膜炎,无4级及以上事件。细胞铺展面积与3级口腔黏膜炎相关(p<0.05),约相当于0.5 Gy剂量。
要点
- 58份可用样本中,34例(58.6%)在中位剂量32 Gy后发生3级口腔黏膜炎。
- 细胞铺展面积与3级口腔黏膜炎相关(p<0.05),约相当于0.5 Gy剂量。
- 人口学与临床参数对细胞铺展试验无显著影响(所有p>0.05)。
核心结论
- 该前瞻性试验表明,口腔角质细胞固有的离体放射敏感性可能与头颈癌患者放疗诱导的口腔黏膜炎相关。
- 这一新型预测指标需要在更大的前瞻性队列中验证。
研究设计与样本
- 前瞻性试验,纳入63例接受放化疗的头颈癌患者,采集健康牙龈黏膜微活检,其中58份样本可用。
- 角质细胞离体增殖、照射后行细胞铺展试验,照射剂量为0、2、4、6或8 Gy,剂量率0.63 Gy min-1。
- 由经过专门培训的检查者每周两次系统临床记录口腔黏膜炎。
主要发现
- 多数患者为淋巴结阳性,肿瘤位于口咽或口腔;绝大多数接受辅助放疗和同步化疗。
- 34例(58.6%)在中位剂量32 Gy后发生3级口腔黏膜炎,无患者发生4级及以上事件。
- 细胞铺展试验面积与3级口腔黏膜炎相关(p<0.05),约相当于0.5 Gy剂量。
- 人口学与临床参数对细胞铺展试验无显著影响(所有p>0.05)。
临床怎么用
- 原文未据此给出推荐。
局限性
- 该新型预测指标需要在更大的前瞻性队列中验证。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
BACKGROUND: Predicting the occurrence and/or severity of oral mucositis (OM) before commencing radiotherapy (RT) remains very difficult. The aim of this prospective trial was to investigate whether the ex-vivo radiation sensitivity of oral keratinocytes from head and neck (H&N) cancer patients correlates with severe OM. METHODS: Oral microbiopsies of healthy gingival mucosa were collected from 63H&N cancer patients undergoing (chemo)RT, of which 58 samples were useable. Keratinocytes from these microbiopsies underwent ex-vivo proliferation, irradiation, and subsequently the cell spreading assay. Tubes with the cell suspension were placed within the irradiation chamber of a 137Cs Gammacell 40 Exactor (Best Theratronics, Canada) and exposed to 0, 2, 4, 6, or 8 Gy at a dose rate of 0.63 Gy min-1. Cell suspension was then immediately pipetted into custom-made polydimethylsiloxane (PDMS) rings.The effect of demographic and clinical parameters on the cell spreading assay were also analyzed. Systematic clinical recording of OM was conducted twice a week by a specially trained examiner. RESULTS: Most patients had node-positive disease and cancer of the oropharynx or oral cavity. The vast majority of patients received adjuvant RT and concurrent chemotherapy. Overall, 34 (58.6 %) participants developed grade 3 OM after a median dose of 32 Gy. No patient experienced a grade ≥ 4 event. There was a correlation between the cell spreading assay area and grade 3 OM (p < 0.05), equivalent to approximately 0.5 Gy dose. Demographic and clinical parameters had no significant impact on the cell spreading assay (p > 0.05 for all). CONCLUSIONS: It is necessary to establish reliable predictors of severe OM before treatment in H&N cancer to allow early management of treatment-related sequelae. This prospective trial illustrates that the intrinsic ex-vivo radiosensitivity of oral keratinocytes could be correlated with RT-induced OM in patients with H&N cancer. This novel predictor requires validation in larger prospective cohorts.
引用
- Thomsen AR, Monroy Ordonez EB, Henke M, et al. Evaluating the radiosensitivity of the oral microbiome to predict radiation-induced mucositis in head and neck cancer patients: A prospective trial. Clin Transl Radiat Oncol. 2025. PMID: 39898328. doi:10.1016/j.ctro.2025.100915
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。